Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
2.
J Pediatr ; 171: 104-10, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26787380

ABSTRACT

OBJECTIVES: To determine across and within hospital differences in the predictors of 365-day admission frequency for diabetic ketoacidosis (DKA) in children at US children's hospitals. STUDY DESIGN: Multicenter retrospective cohort analysis of 12,449 children 2-18 years of age with a diagnosis of DKA in 42 US children's hospitals between 2004 and 2012. The main outcome of interest was the maximum number of DKA admissions experienced by each child within any 365-day interval during a 5-year follow-up period. The association between patient characteristics and the maximum number of DKA admissions within a 365-day interval was examined across and within hospitals. RESULTS: In the sample, 28.3% of patients admitted for DKA experienced at least 1 additional DKA admission within the following 365 days. Across hospitals, patient characteristics associated with increasing DKA admission frequency were public insurance (OR 1.97, 95% CI 1.71-2.26), non-Hispanic black race (OR 2.40, 95% CI 2.02-2.85), age ≥ 12 (OR 1.98, 95% CI 1.7-2.32), female sex (OR 1.41, 95% CI 1.29-1.55), and mental health comorbidity (OR 1.36, 95% CI 1.13-1.62). Within hospitals, non-Hispanic black race was associated with higher odds of 365-day admission in 59% of hospitals, and public insurance was associated with higher odds in 56% of hospitals. Older age, female sex, and mental health comorbidity were associated with higher odds of 365-day admission in 42%, 29%, and 15% of hospitals, respectively. CONCLUSIONS: Across children's hospitals, certain patient characteristics are associated with more frequent DKA admissions. However, these factors are not associated with increased DKA admission frequency for all hospitals.


Subject(s)
Diabetic Ketoacidosis/therapy , Patient Admission/statistics & numerical data , Adolescent , Child , Child, Preschool , Diabetic Ketoacidosis/epidemiology , Female , Hospitalization , Hospitals, Pediatric , Humans , Length of Stay , Male , Multivariate Analysis , Odds Ratio , Retrospective Studies , Treatment Outcome , United States
3.
J Pediatr ; 171: 116-21, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26794472

ABSTRACT

OBJECTIVE: To determine which children with urinary tract infection are likely to have pathogens resistant to narrow-spectrum antimicrobials. STUDY DESIGN: Children, 2-71 months of age (n = 769) enrolled in the Randomized Intervention for Children with Vesicoureteral Reflux or Careful Urinary Tract Infection Evaluation studies were included. We used logistic regression models to test the associations between demographic and clinical characteristics and resistance to narrow-spectrum antimicrobials. RESULTS: Of the included patients, 91% were female and 76% had vesicoureteral reflux. The risk of resistance to narrow-spectrum antibiotics in uncircumcised males was approximately 3 times that of females (OR 3.1; 95% CI 1.4-6.7); in children with bladder bowel dysfunction, the risk was 2 times that of children with normal function (OR 2.2; 95% CI 1.2-4.1). Children who had received 1 course of antibiotics during the past 6 months also had higher odds of harboring resistant organisms (OR 1.6; 95% CI 1.1-2.3). Hispanic children had higher odds of harboring pathogens resistant to some narrow-spectrum antimicrobials. CONCLUSIONS: Uncircumcised males, Hispanic children, children with bladder bowel dysfunction, and children who received 1 course of antibiotics in the past 6 months were more likely to have a urinary tract infection caused by pathogens resistant to 1 or more narrow-spectrum antimicrobials.


Subject(s)
Anti-Infective Agents/pharmacology , Drug Resistance, Bacterial , Urinary Tract Infections/drug therapy , Urinary Tract Infections/microbiology , Amoxicillin/pharmacology , Cephalosporins/pharmacology , Child , Child, Preschool , Escherichia coli , Female , Humans , Infant , Intestinal Diseases/drug therapy , Intestinal Diseases/epidemiology , Intestinal Diseases/microbiology , Male , Nitrofurantoin/pharmacology , Odds Ratio , Regression Analysis , Sulfamethoxazole/pharmacology , Trimethoprim/pharmacology , Urinary Tract Infections/epidemiology , Vesico-Ureteral Reflux/drug therapy , Vesico-Ureteral Reflux/epidemiology , Vesico-Ureteral Reflux/microbiology
4.
J Pediatr Orthop ; 36(6): 634-9, 2016 Sep.
Article in English | MEDLINE | ID: mdl-25929778

ABSTRACT

BACKGROUND: Readmission for surgical-site infection (SSIs) following spinal fusion for NMS impacts costs, patient risk, and family burden; however, it may be preventable. The purpose of this study was to examine variation in hospital performance based on risk-standardized 60-day readmission rates for SSI and reoperation across 39 US Children's Hospitals. METHODS: Retrospective cohort study using the Pediatric Health Information Systems (PHIS) database involving children aged 10 to 18 years with ICD9 codes indicating spinal fusion, scoliosis, and neuromuscular disease discharged from 39 US children's hospitals between January 1, 2007 and September 1, 2012. Readmissions within 60 days for SSI were identified based on the presence of ICD9 codes for (1) infectious complication of device or procedure, or (2) sepsis or specific bacterial infection with an accompanying reoperation. Logistic regression models accounting for patient-level risk factors for SSI were used to estimate expected (patient-level risk across all hospitals) and predicted (weighted average of hospital-specific and all-hospital estimates) outcomes. Relative performance was determined using the hospital-specific predicted versus expected (pe) ratios. RESULTS: Average volume across hospitals ranged from 2 to 23 fusions/quarter and was not associated with readmissions. Of the 7560 children in the cohort, 534 (7%) were readmitted for reoperation and 451 (6%) were readmitted for SSI within 60 days of discharge. Reoperations were associated with an SSI in 70% of cases. Across hospitals, SSI and reoperation rates ranged from 1% to 11% and 1% to 12%, respectively. After adjusting for age, sex, insurance, presence of a gastric tube, ventriculoperitoneal shunt, tracheostomy, prior admissions, number of chronic conditions, procedure type (anterior/posterior), and level (>9 or <9 vertebrae), pe ratios indicating hospital performance varied by 2-fold for each outcome. CONCLUSIONS: After standardizing outcomes using patient-level factors and relative case mix, several hospitals in this cohort were more successful at preventing readmissions for SSIs and reoperations. Closer examination of the organization and implementation of strategies for SSI prevention at high-performing centers may offer valuable clues for improving care at lower performing institutions. LEVEL OF EVIDENCE: Level III.


Subject(s)
Neuromuscular Diseases/complications , Patient Readmission , Reoperation , Scoliosis , Spinal Fusion/adverse effects , Surgical Wound Infection , Adolescent , Child , Female , Hospitals, Pediatric/statistics & numerical data , Humans , Male , Outcome and Process Assessment, Health Care , Patient Readmission/statistics & numerical data , Quality Improvement , Reoperation/methods , Reoperation/statistics & numerical data , Retrospective Studies , Risk Factors , Scoliosis/diagnosis , Scoliosis/etiology , Scoliosis/surgery , Spinal Fusion/methods , Surgical Wound Infection/epidemiology , Surgical Wound Infection/etiology , United States
5.
J Pediatr ; 167(6): 1397-403.e1, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26316371

ABSTRACT

OBJECTIVE: To investigate differences in risk factors for depression and anxiety, such as central nervous system involvement in systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD), by comparing youth with SLE/MCTD to peers with type 1 diabetes mellitus (T1D). STUDY DESIGN: We conducted a cross-sectional study of 50 outpatient pairs, ages 8 years and above, matching subjects with SLE/MCTD and T1D by sex and age group. We screened for depression, suicidal ideation, and anxiety using the Patient Health Questionnaire-9 and the Screen for Childhood Anxiety Related Emotional Disorders, respectively. We collected parent-reported mental health treatment data. We compared prevalence and treatment rates between subjects with SLE/MCTD and T1D, and identified disease-specific risk factors using logistic regression. RESULTS: Depression symptoms were present in 23%, suicidal ideation in 15%, and anxiety in 27% of participants. Compared with subjects with T1D, subjects with SLE/MCTD had lower adjusted rates of depression and suicidal ideation, yet poorer rates of mental health treatment (24% vs 53%). Non-White race/ethnicity and longer disease duration were independent risk factors for depression and suicidal ideation. Depression was associated with poor disease control in both groups, and anxiety with insulin pump use in subjects with T1D. CONCLUSION: Depression and anxiety are high and undertreated in youth with SLE/MCTD and T1D. Focusing on risk factors such as race/ethnicity and disease duration may improve their mental health care. Further study of central nervous system and other disease-related factors may identify targets for intervention.


Subject(s)
Anxiety/epidemiology , Depression/epidemiology , Diabetes Mellitus, Type 1/complications , Lupus Erythematosus, Systemic/complications , Mental Health , Mixed Connective Tissue Disease/complications , Risk Assessment/methods , Adolescent , Anxiety/etiology , Child , Cross-Sectional Studies , Depression/etiology , Diabetes Mellitus, Type 1/psychology , Female , Humans , Lupus Erythematosus, Systemic/psychology , Male , Mixed Connective Tissue Disease/psychology , Pennsylvania/epidemiology , Prevalence , Risk Factors
6.
J Pediatr ; 154(3): 447-9, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19874761

ABSTRACT

Many children with influenza are treated with antibiotics. In this report, we describe the rate and indications for antibacterial use in children hospitalized with influenza. A total of 333 of 729 (46%) patients received >2 days of treatment with antibacterial medications, of whom 36% did not have an apparent indication for therapy.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Child, Hospitalized/statistics & numerical data , Drug Utilization , Hospitals, Pediatric/statistics & numerical data , Influenza, Human/drug therapy , Adolescent , Bacterial Infections/drug therapy , Bacterial Infections/epidemiology , Child , Child, Preschool , Cohort Studies , Community-Acquired Infections/diagnosis , Community-Acquired Infections/drug therapy , Community-Acquired Infections/epidemiology , Comorbidity , Female , Humans , Infant , Influenza, Human/diagnosis , Influenza, Human/epidemiology , Male , Retrospective Studies , Young Adult
7.
J Pediatr ; 155(6): 812-818.e1, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19643437

ABSTRACT

OBJECTIVE: To describe variation regarding inpatient therapy and evaluation of children with Henoch Schönlein purpura (HSP) admitted to children's hospitals across the United States. STUDY DESIGN: We conducted a retrospective cohort study of children discharged with a diagnosis of HSP between 2000 and 2007 by use of inpatient administrative data from 36 children's hospitals. We examined variation among hospitals in the use of medications, diagnostic tests, and intensive care services with multivariate mixed effects logistic regression models. RESULTS: During the initial HSP hospitalization (n = 1988), corticosteroids were the most common medication (56% of cases), followed by opioids (36%), nonsteroidal antiinflammatory drugs (35%), and antihypertensive drugs (11%). After adjustment for patient characteristics, hospitals varied significantly in their use of corticosteroids, opioids, and nonsteroidal antiinflammatory drugs; the use of diagnostic abdominal imaging, endoscopy, laboratory testing, and renal biopsy; and the use of intensive care services. By contrast, hospitals did not differ significantly regarding administration of antihypertensive drugs or performance of skin biopsy. CONCLUSIONS: The significant variation identified may contribute to varying HSP clinical outcomes between hospitals, warrants further investigation, and represents a potentially important opportunity to improve quality of care.


Subject(s)
Hospitalization , Hospitals, Pediatric , IgA Vasculitis/diagnosis , IgA Vasculitis/therapy , Practice Patterns, Physicians' , Adolescent , Child , Child, Preschool , Cohort Studies , Female , Humans , IgA Vasculitis/complications , Infant , Logistic Models , Male , Retrospective Studies , Treatment Outcome , United States
8.
J Pediatr ; 154(6): 789-96, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19324369

ABSTRACT

OBJECTIVES: To describe the variability in outcomes and care processes for children hospitalized for urinary tract infection (UTI), and to identify patient and hospital factors that may account for variability. STUDY DESIGN: Retrospective cohort of children 1 month to 12 years of age hospitalized for UTI at 25 children's hospitals from 1999 to 2004. We measured variability in length-of-stay (LOS), cost, readmission rate, intensive care unit admission, and performance of renal ultrasound and voiding cystourethrogram and identified patient and hospital factors associated with these outcomes. RESULTS: The cohort included 20,892 children. There was significant variation in outcomes and processes of care across hospitals (eg, mean LOS, 2.1-5.0 days; patients with both imaging tests performed, 0.3%-72.9%). Older children had shorter LOS and were less likely to undergo imaging. Patients hospitalized at high volume hospitals were more likely to undergo imaging. Hospitals with high percentage of Medicaid patients had longer LOS and were less likely to perform imaging tests. Hospitals with a clinical practice guideline for UTI had shorter LOS and decreased costs per admission. CONCLUSIONS: The variability across hospitals may represent opportunities for benchmarking, standardization, and quality improvement. Decreased LOS and costs associated with clinical practice guidelines support their implementation.


Subject(s)
Hospitals, Pediatric/statistics & numerical data , Outcome and Process Assessment, Health Care , Urinary Tract Infections/therapy , Child , Child, Preschool , Female , Guideline Adherence , Health Care Costs , Healthcare Disparities , Humans , Infant , Intensive Care Units, Pediatric/statistics & numerical data , Kidney/diagnostic imaging , Length of Stay , Male , Patient Readmission , Practice Guidelines as Topic , Radiography , Radionuclide Imaging , Treatment Outcome , Ultrasonography , Urinary Tract Infections/diagnostic imaging , Urinary Tract Infections/economics
9.
J Pediatr ; 150(3): 306-10, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17307552

ABSTRACT

OBJECTIVE: To determine the characteristics, incidence, and risk factors for influenza-related neurologic complications (INC). STUDY DESIGN: A retrospective cohort study of INC in children hospitalized with laboratory-confirmed influenza infection (LCI) from June 2000 to May 2004 was conducted. Systematic chart review was performed to identify clinical characteristics and outcomes. A neighborhood cohort was constructed to estimate the incidence of INC. Logistic regression was used to identify independent risk factors for INC. RESULTS: Of 842 patients with LCI, 72 patients had an INC: influenza-related encephalopathy (8), post-infectious influenza encephalopathy (2), seizures (56), and other (6). Febrile seizures were the most common type of seizures (27). No patient died from an INC. In our neighborhood cohort, the incidence of INC was 4 cases per 100,000 person-years. An age of 6 to 23 months (odds ratio [OR], 4.2; 95% CI, 1.4-12.5) or 2 to 4 years (OR, 6.3; 95% CI, 2.1-19.1) and an underlying neurologic or neuromuscular disease (OR, 5.6; 95% CI, 3.2-9.6) were independent risk factors for the development of INC. CONCLUSION: Seizures are the most common neurologic complication experienced by children hospitalized with influenza. In the United States, encephalopathy is uncommon. Young children and patients with neurologic or neuromuscular disease are at increased risk for INC.


Subject(s)
Hospitalization/statistics & numerical data , Influenza, Human/complications , Influenza, Human/diagnosis , Nervous System Diseases/epidemiology , Nervous System Diseases/etiology , Age Distribution , Child, Preschool , Cohort Studies , Female , Follow-Up Studies , Humans , Incidence , Infant , Influenza, Human/therapy , Male , Medical Records , Multivariate Analysis , Nervous System Diseases/physiopathology , Probability , Retrospective Studies , Risk Assessment , Seizures, Febrile/epidemiology , Seizures, Febrile/etiology , Seizures, Febrile/physiopathology , Severity of Illness Index , Sex Distribution , Statistics, Nonparametric
SELECTION OF CITATIONS
SEARCH DETAIL